|1.||Matsuoka, Masaaki: 6 articles (06/2010 - 11/2005)|
|2.||Aiso, Sadakazu: 5 articles (07/2008 - 11/2005)|
|3.||Chiba, Tomohiro: 4 articles (07/2008 - 11/2005)|
|4.||Nishimoto, Ikuo: 4 articles (02/2007 - 11/2005)|
|5.||Sasabe, Jumpei: 3 articles (07/2008 - 11/2005)|
|6.||Yamada, Marina: 3 articles (07/2008 - 11/2005)|
|7.||Terashita, Kenzo: 3 articles (07/2008 - 11/2005)|
|8.||Zikos, Christos: 2 articles (02/2015 - 11/2008)|
|9.||Paravatou-Petsotas, Maria: 2 articles (02/2015 - 11/2008)|
|10.||Livaniou, Evangelia: 2 articles (02/2015 - 11/2008)|
|1.||Alzheimer Disease (Alzheimer's Disease)
07/01/2008 - "Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease."
06/01/2010 - "[Colivelin--drug therapy for patients with Alzheimer's disease]."
07/01/2008 - "Humanin (HN) and its derivatives, such as Colivelin (CLN), suppress neuronal death induced by insults related to Alzheimer's disease (AD) by activating STAT3 in vitro. "
11/02/2005 - "Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo."
05/12/2006 - "Here, we found that i.c.v. injection of a synthetic hybrid peptide named Colivelin composed of ADNF and AGA-(C8R)HNG17, a potent derivative of Humanin that is a bioactive peptide with anti-Alzheimer's disease activity, dose-dependently improved motor performance and prolonged survival of ALS mice. "
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
|3.||Memory Disorders (Memory Loss)
11/02/2005 - "In addition, intraperitoneally administered Colivelin suppresses memory impairment caused by a muscarinic acetylcholine receptor antagonist, 3-quinuclidinyl benzilate, indicating that a substantial portion of intraperitoneally administered Colivelin passes through the blood-brain barrier and suppresses functional memory deficit. "
|4.||Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
|6.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
|1.||Drug Therapy (Chemotherapy)